OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR/Cas systems: Delivery and application in gene therapy
Jie Huang, Yitong Zhou, Jie Li, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

CRISPR-Cas for genome editing: Classification, mechanism, designing and applications
Simran Bhatia, P Pooja, Sudesh Kumar Yadav
International Journal of Biological Macromolecules (2023) Vol. 238, pp. 124054-124054
Closed Access | Times Cited: 80

Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug delivery
Alaa A. A. Aljabali, Mohamed El‐Tanani, Murtaza M. Tambuwala
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105338-105338
Open Access | Times Cited: 39

Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets
Maryam Taghdiri, Claudio Mussolino
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7333-7333
Open Access | Times Cited: 22

Enhancing precision in cancer treatment: the role of gene therapy and immune modulation in oncology
Emile M. Youssef, Brandon Fletcher, Dannelle Palmer
Frontiers in Medicine (2025) Vol. 11
Open Access | Times Cited: 3

Sensitive and Amplification-Free Electrochemiluminescence Biosensor for HPV-16 Detection Based on CRISPR/Cas12a and DNA Tetrahedron Nanostructures
Linying Yu, Yao Peng, Mengting Sheng, et al.
ACS Sensors (2023) Vol. 8, Iss. 7, pp. 2852-2858
Closed Access | Times Cited: 40

Targeting MHC-I inhibitory pathways for cancer immunotherapy
Jun Wang, Lu Qiao, Xufeng Chen, et al.
Trends in Immunology (2024) Vol. 45, Iss. 3, pp. 177-187
Closed Access | Times Cited: 12

Utilization of CRISPR-Cas genome editing technology in filamentous fungi: function and advancement potentiality
Qiqing Shen, Haihua Ruan, Hongyang Zhang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9

Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles
Zhidu Song, Tao Ying, Yue Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8

Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Ankit Kumar Dubey, Ebrahim Mostafavi
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 21

CRISPR innovations in tissue engineering and gene editing
ZahraSadat Razavi, M. Soltani, Mohammad Souri, et al.
Life Sciences (2024), pp. 123120-123120
Open Access | Times Cited: 8

Recent Trends and Advancements in CRISPR-Based Tools for Enhancing Resistance against Plant Pathogens
Munazza Ijaz, Fahad Khan, Haitham E. M. Zaki, et al.
Plants (2023) Vol. 12, Iss. 9, pp. 1911-1911
Open Access | Times Cited: 12

CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance
Muhammad Shahzad Rafiq, Muhammad Abubakar Shabbir, Ahmed Raza, et al.
BioDrugs (2024) Vol. 38, Iss. 3, pp. 387-404
Closed Access | Times Cited: 4

Cas12a Is Competitive for Gene Editing in the Malaria parasites
Shijie Yang, Yiming Wei, Elvis Quansah, et al.
Microbial Pathogenesis (2025), pp. 107340-107340
Closed Access

Gene Therapy with Gene Delivery Systems and Therapeutic Strategies: A New Frontier in Cancer Treatment
Thippenahalli Narasimhaiah Ramakrishnaiah, Sowbhagya Ramachandregowda, Harsha Muktha, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106798-106798
Closed Access

Nanotechnology in Gene Editing: Pioneering CRISPR‐Cas Delivery Systems to Tackle Antibiotic Resistance
Sahar Gholamian, Pooya Baghaee, Mohammad Doroudian
Advanced Therapeutics (2025)
Closed Access

Protocol Development for CRISPR/Cas9 Knockout of the Anti-inflammatory Protein TNIP1 in HaCaT Keratinocytes
Liam E. Carman, Michael L. Samulevich, Brian J. Aneskievich
Methods in molecular biology (2025)
Closed Access

Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications
Xinmei Liu, Mengyu Gao, Ji Bao
Nanomaterials (2025) Vol. 15, Iss. 7, pp. 540-540
Open Access

A bibliometric mapping of advancements and trends in genome editing in pigs
Jaya Bharati, Satish Kumar, Salam Jayachitra Devi, et al.
Tropical Animal Health and Production (2025) Vol. 57, Iss. 4
Open Access

CRISPR‐Cas9 technology: As an efficient genome modification tool in the cancer diagnosis and treatment
Ghazaleh Behrouzian Fard, Mohammad Hossein Ahmadi, Mehran Gholamin, et al.
Biotechnology and Bioengineering (2023) Vol. 121, Iss. 2, pp. 472-488
Closed Access | Times Cited: 9

Strategies for small extracellular vesicle-based cancer immunotherapy
Yundi Chen, Shasha Tang, Fengfeng Cai, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 3

Recent advances and applications of the CRISPR-Cas system in the gene therapy of blood disorders
Saeed Zanganeh, Amir Mohammad Zahedi, Mahla Sattarzadeh Bardsiri, et al.
Gene (2024) Vol. 931, pp. 148865-148865
Closed Access | Times Cited: 3

Carbon-based nanomaterials for CRISPR/Cas delivery: a perspective on the design approach
Moein Safarkhani, Mohammad Reza Saeb, Jeong‐Hwan Lee, et al.
Carbon letters (2023) Vol. 34, Iss. 1, pp. 387-397
Closed Access | Times Cited: 9

Page 1 - Next Page

Scroll to top